Sourabh Arora1, Masahiro Maeda2, Brian Francis3, Mariko Maeda4, Arthur J Sit5, Sameh Mosaed6, Samir Nazarali7, Karim F Damji8. 1. Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta. 2. Yasuma Eye Clinic, Nagoya, Japan. 3. Department of Ophthalmology, University of Southern California, Los Angeles, CA. 4. Maeda Eye Clinic, Osaka, Japan. 5. Department of Ophthalmology, Mayo Clinic, Rochester, MN. 6. Department of Ophthalmology University of California Irvine, Irvine, CA. 7. Faculty of Medicine, University of Ottawa, Ottawa, Ont. 8. Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, Alta.. Electronic address: kdamji@ualberta.ca.
Abstract
OBJECTIVE: To determine the efficacy and safety of ab interno trabeculectomy with Trabectome in juvenile open-angle glaucoma (JOAG) patients. DESIGN: Prospective cohort study. METHODS: Evaluation of the 12-month results of 2 patient groups receiving ab interno trabeculectomy: group 1, eyes with no prior incisional surgery; group 2, eyes that had prior incisional cataract or glaucoma surgery. RESULTS: Group 1, 40 eyes (average age 31 ± 7 years), had a significant reduction in intraocular pressure (IOP) of 10.6 mm Hg at 12 months from a baseline of 27.4 mm Hg (p = 0.01), and the number of glaucoma medications reduced by 0.4 (p = 0.80). Four eyes (10%) within the study period required a secondary glaucoma surgery. Group 2, 20 eyes (average age 27 ± 8 years), had a significant reduction in IOP of 8.8 mm Hg from a baseline of 27.1 mm Hg (p = 0.06), and the number of glaucoma medications reduced by 1.4 (p = 0.36). Five eyes (25%) from this group underwent a secondary glaucoma surgery within 12 months. CONCLUSION: After 1 year of follow-up, ab interno trabeculectomy appears to be an effective and safe intervention for patients with JOAG; however, a reduction in use of topical medications may not be observed in those receiving ab interno trabeculectomy as a primary procedure.
OBJECTIVE: To determine the efficacy and safety of ab interno trabeculectomy with Trabectome in juvenile open-angle glaucoma (JOAG) patients. DESIGN: Prospective cohort study. METHODS: Evaluation of the 12-month results of 2 patient groups receiving ab interno trabeculectomy: group 1, eyes with no prior incisional surgery; group 2, eyes that had prior incisional cataract or glaucoma surgery. RESULTS: Group 1, 40 eyes (average age 31 ± 7 years), had a significant reduction in intraocular pressure (IOP) of 10.6 mm Hg at 12 months from a baseline of 27.4 mm Hg (p = 0.01), and the number of glaucoma medications reduced by 0.4 (p = 0.80). Four eyes (10%) within the study period required a secondary glaucoma surgery. Group 2, 20 eyes (average age 27 ± 8 years), had a significant reduction in IOP of 8.8 mm Hg from a baseline of 27.1 mm Hg (p = 0.06), and the number of glaucoma medications reduced by 1.4 (p = 0.36). Five eyes (25%) from this group underwent a secondary glaucoma surgery within 12 months. CONCLUSION: After 1 year of follow-up, ab interno trabeculectomy appears to be an effective and safe intervention for patients with JOAG; however, a reduction in use of topical medications may not be observed in those receiving ab interno trabeculectomy as a primary procedure.